Clinical Outcomes of N1b Papillary Thyroid Cancer Patients Treated with Two Different Doses of Radioiodine Ablation Therapy

BACKGROUND: The optimal dose of radioactive iodine (RAI) therapy for N1b papillary thyroid carcinoma (PTC) is controversial. We evaluated the clinical outcome of N1b PTC patients treated with either 100 or 150 mCi of RAI. METHODS: We retrospectively analyzed N1b PTC patients who underwent total thyr...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Endocrinol Metab (Seoul)
Main Authors: Jin, Meihua, Ahn, Jonghwa, Lee, Yu-Mi, Sung, Tae-Yon, Kim, Won Gu, Kim, Tae Yong, Ryu, Jin-Sook, Kim, Won Bae, Shong, Young Kee, Jeon, Min Ji
Format: Artigo
Jezik:Inglês
Izdano: Korean Endocrine Society 2020
Teme:
Original Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC7520585/
https://ncbi.nlm.nih.gov/pubmed/32981302
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3803/EnM.2020.741
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki